CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
29 août 2024 03h01 HE
|
CancerVAX, Inc
Santa Barbara, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 29, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that will...
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
27 août 2024 03h01 HE
|
CancerVAX, Inc
Santa Barbara, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 27, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that will...
CancerVax Adds Key Members to Its Research Team
01 août 2024 03h01 HE
|
CancerVAX, Inc
Santa Barbara, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, August 1, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune...
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
21 mai 2024 03h00 HE
|
CancerVAX, Inc
Santa Barbara, May 21, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, May 21, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system...
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
16 avr. 2024 03h01 HE
|
CancerVAX, Inc
Santa Barbara, April 16, 2024 (GLOBE NEWSWIRE) -- Santa Barbara, CA, April 16, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune...
CancerVax Launches $5 Million Funding Round
03 avr. 2024 03h01 HE
|
CancerVAX, Inc
Lehi, Utah, April 03, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., developer of a breakthrough Universal Cancer Vaccine treatment that will use the body’s immune system to fight cancer, today announced...
CancerVAX CEO Ryan Davies Discusses Cancer Drug Development with Dr. Ezra Cohen
02 nov. 2023 09h08 HE
|
CancerVAX, Inc
LEHI, Utah, Nov. 02, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that uses the body’s immune system to fight cancer, today announced that in a...
CancerVAX CEO Ryan Davies Discusses the Company’s Growing Pipeline of Cancer Treatments
14 sept. 2023 03h01 HE
|
CancerVAX, Inc
LEHI, Utah, Sept. 14, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., a pre-clinical biotechnology company working with UCLA to develop breakthrough immunotherapy cancer treatments that use the body’s...
CancerVAX Expands Development Pipeline to Include a Universal CAR-T Cell Platform
12 sept. 2023 03h01 HE
|
CancerVAX, Inc
LEHI, Utah, Sept. 12, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., a pre-clinical biotechnology company working with UCLA to develop breakthrough immunotherapy cancer treatments that use the body’s...
CancerVAX CEO Ryan Davies Discussed Cancer Immunotherapy with UCLA Physician-Scientist
24 août 2023 03h01 HE
|
CancerVAX, Inc
LEHI, Utah, Aug. 24, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that uses the body’s immune system to fight cancer, today announced that in a...